Editorial Comment on “Atopic outcomes at 2 years in the CORAL cohort, born in COVID‐19 lockdown” DOI
Mónica Sandoval, Carmen Riggioni, Jon Genuneit

et al.

Pediatric Allergy and Immunology, Journal Year: 2023, Volume and Issue: 34(11)

Published: Nov. 1, 2023

Language: Английский

COVID-19 vaccination: challenges in the pediatric population DOI Creative Commons

Alice Azoicăi,

Ingrith Miron, Ancuţa Ignat

et al.

Frontiers in Public Health, Journal Year: 2025, Volume and Issue: 12

Published: Jan. 29, 2025

Vaccination is considered to be one of the most effective means protecting individuals and populations from risks associated with exposure various pathogens. The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), affected people all ages worldwide. In response, several pharmaceutical companies rapidly leveraged their resources develop vaccines within a very short period time, leading introduction new, improved, combination for community-wide immunization. This review aims provide summary available literature on efficacy safety in pediatric population ranging 0 18 years. An analysis recent published studies reveals that majority clinical trials have reported sustained immune response following vaccination children across age groups authors highlighted effectiveness immunization schedules adolescents. population-level this remains determined, provided benefits outweigh potential risks. Long-term side effects must still monitored enable development safer more future pandemics.

Language: Английский

Citations

0

Exploring long-term psychological effects of bronchiolitis and influenza in school-aged children DOI Creative Commons
Pankaj Soni,

Jenny Cheriathu

Frontiers in Pediatrics, Journal Year: 2025, Volume and Issue: 13

Published: March 10, 2025

Introduction This systematic review assessed the long-term psychological effects of severe respiratory infections—namely, bronchiolitis and influenza—in school-aged children (5–12 years). Methods PubMed, EMBASE, Cochrane Library were searched for randomized controlled trials, cohort longitudinal studies on years) with a history or influenza infection in early childhood published between 2014 2022. Studies evaluating outcomes at least 6 months post-infection included. Results Several that included this reported increased risks anxiety disorders, depression, attention deficit among those infections childhood. Additionally, prolonged follow-up periods often higher incidence morbidity children. However, some did not detect significant adverse effects, implying timely interventions supportive care may minimize negative outcomes. underscores necessity mental health support following children, highlights need further research biological psychosocial pathways linking illnesses to outcomes, emphasizes value multidisciplinary treatment strategies such comorbidities. Conclusions The findings provide insights healthcare practitioners, policymakers, researchers consider aimed improving affected

Language: Английский

Citations

0

Effects of Early-Life Air Pollution Exposure on Childhood COVID-19 Infection and Sequelae in China DOI
Chan Lu,

Wen Deng,

Zipeng Qiao

et al.

Journal of Hazardous Materials, Journal Year: 2025, Volume and Issue: unknown, P. 137940 - 137940

Published: March 1, 2025

Language: Английский

Citations

0

Allergic diseases and immunodeficiencies in children, lessons learnt from COVID‐19 pandemic by 2022: A statement from the EAACI‐section on pediatrics DOI
Daniel Munblit, Matthew Greenhawt, Helen A. Brough

et al.

Pediatric Allergy and Immunology, Journal Year: 2022, Volume and Issue: 33(10)

Published: Sept. 30, 2022

Abstract By the April 12, 2022, COVID‐19 pandemic had resulted in over half a billion people being infected worldwide. There have been 6.1 million deaths directly due to infection, but has many more short‐ and long‐term pervasive effects on physical mental health of population. Allergic diseases are among most prevalent noncommunicable chronic pediatric population, health‐care professionals researchers were seeking answers since beginning pandemic. Children at lower risk developing severe or dying from infection. not associated with higher severity mortality, apart severe/poorly controlled asthma. The disrupted routine care, mitigation strategies, including limited telemedicine, successfully implemented continue delivery high‐standard care. Although children faced multitude pandemic‐related issues, allergic conditions effectively treated remotely while reduction air pollution lack contact outdoor allergens improvement, particularly respiratory allergies. is no evidence recommend substantial changes usual management modalities children, allergen immunotherapy use biologicals. greater multisystem inflammatory syndrome development, some associations Long COVID reported, although data limited, further research needed. This statement EAACI Section Pediatrics provides recommendations based lessons learnt pandemic, as available evidence.

Language: Английский

Citations

16

COVID-19 and Its Impact on Common Diseases in the Allergy Clinics DOI
Emek Kocatürk, Elissa M. Abrams, Marcus Maurer

et al.

The Journal of Allergy and Clinical Immunology In Practice, Journal Year: 2023, Volume and Issue: 11(11), P. 3289 - 3303

Published: Sept. 1, 2023

Language: Английский

Citations

5

The Long Road of Long COVID: Specific Considerations for the Allergist/Immunologist DOI
Joseph A. Bellanti, Péter Novák, Yoram Faitelson

et al.

The Journal of Allergy and Clinical Immunology In Practice, Journal Year: 2023, Volume and Issue: 11(11), P. 3335 - 3345

Published: Sept. 27, 2023

Language: Английский

Citations

5

Recent insights into the impacts of COVID-19 on pediatric asthma DOI
C. Alves, Raquel Baptista Pestana, Mário Morais‐Almeida

et al.

Expert Review of Clinical Immunology, Journal Year: 2024, Volume and Issue: 20(11), P. 1347 - 1366

Published: Aug. 13, 2024

Introduction The emergence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the subsequent coronavirus disease 2019 (COVID-19) pandemic has raised questions about its impact on pediatric asthma. This review analyzes latest research to offer a comprehensive understanding dynamics between COVID-19

Language: Английский

Citations

1

“Inborn errors of immunity: An expanding horizon through a multitude of biological pathways” DOI
Fabio Candotti, Philippe Eigenmann

Pediatric Allergy and Immunology, Journal Year: 2023, Volume and Issue: 34(1)

Published: Jan. 1, 2023

Language: Английский

Citations

1

КЫРГЫЗ РЕСПУБЛИКАСЫНДАГЫ БРОНХИАЛДЫК АСТМА МЕНЕН ООРУГАН БАЛАЛАРДЫН КОВИД-19 ПНЕВМОНИЯСЫНЫН ӨЗГӨЧӨЛҮКТӨРҮ DOI Open Access

С.Э. Омушева,

Б.Т. Турдалиева

Deleted Journal, Journal Year: 2023, Volume and Issue: 4, P. 134 - 141

Published: Oct. 10, 2023

Цель исследования: провести ретроспективный анализ особенностей течения клинической картины пневмонии с положительными и отрицательными тестами на COVID-19 у детей бронхиальной астмой в Кыргызской Республике. Материалы методы. В исследовании «случай-контроль» сравнивали две группы возрасте от 7 до 17 лет, болевших сентября 2020г по февраль 2021г. Изучены клинико-лабораторные характеристики Covid-19 астмой. Результаты: картина отличалась обычной БА (р <0,001). Выявлена корреляционная связь между данными анамнезе заболевания существующей (p Выводы: наблюдалась восприимчивость к Дети неконтролируемой имели повышенный риск госпитализации более тяжелое течение. Изилдөөнүн максаты: Кыргыз Республикасындагы балдарда бронхиалдык астмасы бар үчүн оң жана терс тесттер менен пневмониянын клиникалык көрүнүшүнүн мүнөздөмөсүнө ретроспективдүү талдоо жүргүзүү. Материалдар ыкмалар. Кейс-контролдук изилдөө 2020-жылдын сентябрынан 2021-жылдын февралына чейин ооруган жаштан жашка чейинки эки топту салыштырды. Бронхиалдык балдардагы Ковид-19 пневмониясынын лабораториялык мүнөздөмөлөрү изилденген. Натыйжалар: формасы астма кадимки пневмониядан айырмаланган балдардын анамнезиндеги маалыматтар учурдагы ооруларынын ортосунда корреляция аныкталган Корутунду: Ковид-19га кабылуу байкалган. Көзөмөлсүз ооруканага жаткыруу коркунучу жогорулаган оорлошкон. Purpose of the study: to conduct a retrospective analysis characteristics clinical picture pneumonia with positive and negative tests for in children bronchial asthma Kyrgyz Republic. Materials methods. The case-control study compared two groups aged years who were ill from September 2020 February 2021. laboratory studied. Results: pattern differed usual (p<0.001). A correlation was identified between data anamnesis diseases existing Conclusions: Susceptibility observed asthma. Children uncontrolled had an increased risk hospitalization more severe

Language: Русский

Citations

1

Impact of the COVID-19 Epidemic on Inhalant Allergen Sensitization in Children DOI Creative Commons
Xueshan Huang, Min Yang, Ye Ma

et al.

Journal of Immunology Research, Journal Year: 2024, Volume and Issue: 2024, P. 1 - 9

Published: Jan. 16, 2024

Objective. To explore the impact of non-pharmacological interventions on inhaled allergen sensitization in children during COVID-19 pandemic. Methods. The positive rate allergens, allergens sIgE grade, and multiple rates before pandemic were analyzed retrospectively this study. Logistic regression analysis was used to compare pandemic, using odds ratio (OR) OR 95% CI investigate sensitization. Results. Positive d1 (49.5% vs. 38.5%), d2 (50.2% 32.2%), e2 (10.1% 6.1%), e1 (6.2% 1.7%), mx2 2.7%), sycamore (7.2% 2.1%), w1 (4.0% elm (3.1% 0.6%), w6 (3.0% u80 (1.3% 0.5%) increased significantly After adjusting gender, age, season, other potential influencing factors, found be a risk factor for (OR = 1.174, 1.015–1.358), 1.301, 1.093–1.549), 1.499, 1.280–1.756), 3.959, 3.358–4.446), 1.828, 1.353–2.470, 1.538, 1.123–2.106)), 2.521, 1.413–4.497) ( P<0.05 ). In addition, grades (d1: χ2 9.576, id="M2">P<0.05 ; d2: 39.063, id="M3">P<0.05 proportion allergies higher than that with statistical significance (χ2 1621.815, id="M4">P<0.05 Conclusion. During both indoor outdoor children. grade dust mite those COVID-19.

Language: Английский

Citations

0